Adnan El-Achkar1, Luis Souhami2, Wassim Kassouf3. 1. Experimental surgery, McGill University Health Center, 1001 Decarie Blvd, Montreal, QC, H4A 3J1, Canada. 2. Department of Radiation Oncology, McGill University Health Center, 1001 Decarie Blvd, Montreal, QC, H4A 3J1, Canada. 3. Department of Surgery, McGill University Health Center, McGill University, 1001 Decarie Blvd, D02.7210, Montreal, QC, H4A 3J1, Canada. wassim.kassouf@muhc.mcgill.ca.
Abstract
PURPOSE OF THE REVIEW: This review targets the latest literature on bladder preservation therapy with emphasis on trimodal therapy (TMT), highlighting its role in the management of muscle invasive bladder cancer (MIBC) and outlining future directions in bladder preservation research. RECENT FINDINGS: TMT is the most promising bladder preservation treatment modality. Comparable results to contemporary radical cystectomy series are seen in properly selected patients. A multidisciplinary team approach is critical in the management of these patients. Future research is directed at the integration of immunotherapy into the treatment protocol. TMT, involving maximal transurethral resection followed by chemoradiation, is an attractive alternative to radical cystectomy with urinary diversion in carefully selected patients with muscle invasive disease. In the absence of randomized trial (RCT), comparison between TMT and cystectomy, based on retrospective data from large centers, suggests comparable oncological outcomes, with a favorable impact on quality of life.
PURPOSE OF THE REVIEW: This review targets the latest literature on bladder preservation therapy with emphasis on trimodal therapy (TMT), highlighting its role in the management of muscle invasive bladder cancer (MIBC) and outlining future directions in bladder preservation research. RECENT FINDINGS:TMT is the most promising bladder preservation treatment modality. Comparable results to contemporary radical cystectomy series are seen in properly selected patients. A multidisciplinary team approach is critical in the management of these patients. Future research is directed at the integration of immunotherapy into the treatment protocol. TMT, involving maximal transurethral resection followed by chemoradiation, is an attractive alternative to radical cystectomy with urinary diversion in carefully selected patients with muscle invasive disease. In the absence of randomized trial (RCT), comparison between TMT and cystectomy, based on retrospective data from large centers, suggests comparable oncological outcomes, with a favorable impact on quality of life.
Authors: Raymond H Mak; Daniel Hunt; William U Shipley; Jason A Efstathiou; William J Tester; Michael P Hagan; Donald S Kaufman; Niall M Heney; Anthony L Zietman Journal: J Clin Oncol Date: 2014-11-03 Impact factor: 44.544
Authors: Ross E Krasnow; Michael Drumm; Hannah J Roberts; Andrzej Niemierko; Chin-Lee Wu; Shulin Wu; Jing Zhang; Niall M Heney; Matthew F Wszolek; Michael L Blute; Adam S Feldman; Richard J Lee; Anthony L Zietman; William U Shipley; Jason A Efstathiou Journal: Eur Urol Date: 2016-12-28 Impact factor: 20.096
Authors: M H Hussain; T R Glass; J Forman; W Sakr; D C Smith; M Al-Sarraf; J Jones; S P Balcerzak; E D Crawford; H B Grossman Journal: J Urol Date: 2001-01 Impact factor: 7.450
Authors: Thomas Seisen; Maxine Sun; Stuart R Lipsitz; Firas Abdollah; Jeffrey J Leow; Mani Menon; Mark A Preston; Lauren C Harshman; Adam S Kibel; Paul L Nguyen; Joaquim Bellmunt; Toni K Choueiri; Quoc-Dien Trinh Journal: Eur Urol Date: 2017-04-12 Impact factor: 20.096
Authors: Robert A Huddart; Emma Hall; Syed A Hussain; Peter Jenkins; Christine Rawlings; Jean Tremlett; Malcolm Crundwell; Fawzi A Adab; Denise Sheehan; Isabel Syndikus; Carey Hendron; Rebecca Lewis; Rachel Waters; Nicholas D James Journal: Int J Radiat Oncol Biol Phys Date: 2013-10-01 Impact factor: 7.038
Authors: Ronald Kool; Ivan Yanev; Tarek Hijal; Marie Vanhuyse; Fabio L Cury; Luis Souhami; Wassim Kassouf; Alice Dragomir Journal: Can Urol Assoc J Date: 2022-06 Impact factor: 2.052
Authors: Deborah W Knapp; Deepika Dhawan; José A Ramos-Vara; Timothy L Ratliff; Gregory M Cresswell; Sagar Utturkar; Breann C Sommer; Christopher M Fulkerson; Noah M Hahn Journal: Front Oncol Date: 2020-01-21 Impact factor: 6.244
Authors: Ben-Max de Ruiter; Maaike W van de Kamp; Jonah P Z van Steenbergen; Martine Franckena; Joost L Boormans; Jeantine M de Feijter; Adriaan D Bins; Maarten C C M Hulshof; Theo M de Reijke; Eva Schaake; Jorg R Oddens Journal: Eur Urol Open Sci Date: 2022-03-16